Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of QSant™ for Underlying Allograft Rejection (AQUA Registry)

NCT05282966 is registered in ClinicalTrials.gov with NephroSant as lead sponsor.

NCT NCT05282966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of QSant™ for Underlying Allograft Rejection (AQUA Registry)
Lead sponsor
NephroSant
Phase
Observational
Overall status
Not yet recruiting
Start date
March 31, 2023
Completion date
October 31, 2026
Enrollment
4,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant failure and rejection